Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | (-)-epigallocatechin 3-gallate | multiple interactions | ISO | WASF2 (Homo sapiens) | 6480464 | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of WASF2 mRNA | CTD | PMID:22079256 | 1,2-dimethylhydrazine | affects expression | ISO | Wasf2 (Mus musculus) | 6480464 | 1 and 2-Dimethylhydrazine affects the expression of WASF2 mRNA | CTD | PMID:22206623 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Wasf2 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of WASF2 mRNA | CTD | PMID:21570461 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of WASF2 mRNA | CTD | PMID:33387578 | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of WASF2 mRNA | CTD | PMID:34747641 | 2,4-dinitrotoluene | affects expression | EXP | | 6480464 | 2 and 4-dinitrotoluene affects the expression of WASF2 mRNA | CTD | PMID:21346803 | 2,6-dinitrotoluene | affects expression | EXP | | 6480464 | 2 and 6-dinitrotoluene affects the expression of WASF2 mRNA | CTD | PMID:21346803 | 3,4-methylenedioxymethamphetamine | decreases expression | ISO | Wasf2 (Mus musculus) | 6480464 | N-Methyl-3 and 4-methylenedioxyamphetamine results in decreased expression of WASF2 mRNA | CTD | PMID:26251327 | 4,4'-sulfonyldiphenol | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of WASF2 mRNA | CTD | PMID:36041667 | acetamide | increases expression | EXP | | 6480464 | acetamide results in increased expression of WASF2 mRNA | CTD | PMID:31881176 | aflatoxin B1 | increases methylation | ISO | WASF2 (Homo sapiens) | 6480464 | Aflatoxin B1 results in increased methylation of WASF2 3' UTR more ... | CTD | PMID:30157460 | Aflatoxin B2 alpha | increases methylation | ISO | WASF2 (Homo sapiens) | 6480464 | aflatoxin B2 results in increased methylation of WASF2 intron | CTD | PMID:30157460 | all-trans-retinoic acid | decreases expression | ISO | Wasf2 (Mus musculus) | 6480464 | Tretinoin results in decreased expression of WASF2 mRNA | CTD | PMID:16788091 | all-trans-retinoic acid | decreases expression | ISO | WASF2 (Homo sapiens) | 6480464 | Tretinoin results in decreased expression of WASF2 mRNA | CTD | PMID:23724009 | arsenite(3-) | increases expression | ISO | Wasf2 (Mus musculus) | 6480464 | arsenite results in increased expression of WASF2 mRNA | CTD | PMID:18191166 | arsenite(3-) | increases methylation | ISO | WASF2 (Homo sapiens) | 6480464 | arsenite results in increased methylation of WASF2 promoter | CTD | PMID:23974009 | atrazine | increases expression | ISO | WASF2 (Homo sapiens) | 6480464 | Atrazine results in increased expression of WASF2 mRNA | CTD | PMID:22378314 | benzo[a]pyrene | increases methylation | ISO | WASF2 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in increased methylation of WASF2 5' UTR | CTD | PMID:27901495 | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of WASF2 mRNA | CTD | PMID:25181051 | bisphenol A | increases expression | ISO | Wasf2 (Mus musculus) | 6480464 | bisphenol A results in increased expression of WASF2 mRNA | CTD | PMID:32156529 | bisphenol A | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of WASF2 mRNA | CTD | PMID:36041667 | bisphenol A | decreases expression | ISO | WASF2 (Homo sapiens) | 6480464 | bisphenol A results in decreased expression of WASF2 protein | CTD | PMID:31675489 | bisphenol A | affects expression | EXP | | 6480464 | bisphenol A affects the expression of WASF2 mRNA | CTD | PMID:32145629 | bisphenol F | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of WASF2 mRNA | CTD | PMID:36041667 | butan-1-ol | multiple interactions | ISO | WASF2 (Homo sapiens) | 6480464 | [[Gasoline co-treated with 1-Butanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of WASF2 mRNA | CTD | PMID:29432896 | cadmium atom | multiple interactions | ISO | WASF2 (Homo sapiens) | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of WASF2 mRNA | CTD | PMID:35301059 | cadmium dichloride | multiple interactions | ISO | WASF2 (Homo sapiens) | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of WASF2 mRNA | CTD | PMID:35301059 | caffeine | decreases phosphorylation | ISO | WASF2 (Homo sapiens) | 6480464 | Caffeine results in decreased phosphorylation of WASF2 protein | CTD | PMID:35688186 | cannabidiol | affects methylation | EXP | | 6480464 | Cannabidiol affects the methylation of WASF2 gene | CTD | PMID:30521419 | carbon nanotube | decreases expression | ISO | Wasf2 (Mus musculus) | 6480464 | Nanotubes and Carbon results in decreased expression of WASF2 mRNA | CTD | PMID:25554681 | carmustine | affects response to substance | ISO | WASF2 (Homo sapiens) | 6480464 | WASF2 mRNA affects the susceptibility to Carmustine | CTD | PMID:16365179 | CGP 52608 | multiple interactions | ISO | WASF2 (Homo sapiens) | 6480464 | CGP 52608 promotes the reaction [RORA protein binds to WASF2 gene] | CTD | PMID:28238834 | chloroprene | increases expression | EXP | | 6480464 | Chloroprene results in increased expression of WASF2 mRNA | CTD | PMID:23125180 | cobalt dichloride | increases expression | ISO | WASF2 (Homo sapiens) | 6480464 | cobaltous chloride results in increased expression of WASF2 mRNA | CTD | PMID:19376846 | cyclosporin A | increases expression | ISO | WASF2 (Homo sapiens) | 6480464 | Cyclosporine results in increased expression of WASF2 mRNA | CTD | PMID:20106945 and PMID:25562108 | Di-n-octyl phthalate | decreases expression | ISO | Wasf2 (Mus musculus) | 6480464 | di-n-octyl phthalate results in decreased expression of WASF2 mRNA | CTD | PMID:37810885 | dicrotophos | increases expression | ISO | WASF2 (Homo sapiens) | 6480464 | dicrotophos results in increased expression of WASF2 mRNA | CTD | PMID:28302478 | dioxygen | multiple interactions | ISO | Wasf2 (Mus musculus) | 6480464 | [sulforaphane affects the susceptibility to Oxygen] which affects the expression of WASF2 mRNA | CTD | PMID:30529165 | diuron | decreases expression | EXP | | 6480464 | Diuron results in decreased expression of WASF2 mRNA | CTD | PMID:25152437 | dorsomorphin | multiple interactions | ISO | WASF2 (Homo sapiens) | 6480464 | [NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of WASF2 mRNA | CTD | PMID:27188386 | elemental selenium | increases expression | ISO | WASF2 (Homo sapiens) | 6480464 | Selenium results in increased expression of WASF2 mRNA | CTD | PMID:19244175 | elemental selenium | multiple interactions | ISO | WASF2 (Homo sapiens) | 6480464 | [Selenium co-treated with Vitamin E] results in increased expression of WASF2 mRNA | CTD | PMID:19244175 | epoxiconazole | affects expression | ISO | Wasf2 (Mus musculus) | 6480464 | epoxiconazole affects the expression of WASF2 mRNA | CTD | PMID:35436446 | ethanol | multiple interactions | ISO | WASF2 (Homo sapiens) | 6480464 | [[Gasoline co-treated with Ethanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of WASF2 mRNA | CTD | PMID:29432896 | ethanol | increases expression | ISO | Wasf2 (Mus musculus) | 6480464 | Ethanol results in increased expression of WASF2 mRNA | CTD | PMID:30319688 | ethyl methanesulfonate | increases expression | ISO | WASF2 (Homo sapiens) | 6480464 | Ethyl Methanesulfonate results in increased expression of WASF2 mRNA | CTD | PMID:23649840 | fenamidone | increases expression | ISO | Wasf2 (Mus musculus) | 6480464 | fenamidone results in increased expression of WASF2 mRNA | CTD | PMID:27029645 | fenthion | decreases expression | ISO | Wasf2 (Mus musculus) | 6480464 | Fenthion results in decreased expression of WASF2 mRNA | CTD | PMID:34813904 | formaldehyde | increases expression | ISO | WASF2 (Homo sapiens) | 6480464 | Formaldehyde results in increased expression of WASF2 mRNA | CTD | PMID:23649840 | FR900359 | decreases phosphorylation | ISO | WASF2 (Homo sapiens) | 6480464 | FR900359 results in decreased phosphorylation of WASF2 protein | CTD | PMID:37730182 | glyphosate | increases expression | ISO | Wasf2 (Mus musculus) | 6480464 | Glyphosate results in increased expression of WASF2 mRNA | CTD | PMID:35897073 | isobutanol | multiple interactions | ISO | WASF2 (Homo sapiens) | 6480464 | [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of WASF2 mRNA | CTD | PMID:29432896 | ivermectin | decreases expression | ISO | WASF2 (Homo sapiens) | 6480464 | Ivermectin results in decreased expression of WASF2 protein | CTD | PMID:32959892 | lead diacetate | decreases expression | ISO | Wasf2 (Mus musculus) | 6480464 | lead acetate results in decreased expression of WASF2 mRNA | CTD | PMID:21829687 | lipopolysaccharide | multiple interactions | ISO | Wasf2 (Mus musculus) | 6480464 | LRRK2 protein affects the reaction [Lipopolysaccharides results in increased expression of WASF2 protein] and WASF2 protein affects the reaction [LRRK2 protein affects the reaction [Lipopolysaccharides results in increased secretion of IL1B protein]] | CTD | PMID:32247534 | lipopolysaccharide | increases expression | ISO | Wasf2 (Mus musculus) | 6480464 | Lipopolysaccharides results in increased expression of WASF2 protein | CTD | PMID:32247534 | manganese(II) chloride | increases expression | ISO | Wasf2 (Mus musculus) | 6480464 | manganese chloride results in increased expression of WASF2 mRNA | CTD | PMID:17467022 | methamphetamine | increases expression | ISO | Wasf2 (Mus musculus) | 6480464 | Methamphetamine results in increased expression of WASF2 mRNA | CTD | PMID:26307267 | methyl methanesulfonate | increases expression | ISO | WASF2 (Homo sapiens) | 6480464 | Methyl Methanesulfonate results in increased expression of WASF2 mRNA | CTD | PMID:23649840 | methylmercury chloride | increases expression | ISO | WASF2 (Homo sapiens) | 6480464 | methylmercuric chloride results in increased expression of WASF2 mRNA | CTD | PMID:23179753 and PMID:26272509 | methylmercury chloride | multiple interactions | ISO | WASF2 (Homo sapiens) | 6480464 | [NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of WASF2 mRNA | CTD | PMID:27188386 | paracetamol | affects expression | ISO | Wasf2 (Mus musculus) | 6480464 | Acetaminophen affects the expression of WASF2 mRNA | CTD | PMID:17562736 | paracetamol | decreases expression | EXP | | 6480464 | Acetaminophen results in decreased expression of WASF2 mRNA | CTD | PMID:33387578 | paraquat | multiple interactions | ISO | Wasf2 (Mus musculus) | 6480464 | [LRRK2 protein results in increased susceptibility to Paraquat] which results in increased expression of WASF2 protein | CTD | PMID:31174552 | paraquat | decreases expression | ISO | Wasf2 (Mus musculus) | 6480464 | Paraquat results in decreased expression of WASF2 protein | CTD | PMID:31174552 | potassium chromate | increases expression | ISO | WASF2 (Homo sapiens) | 6480464 | potassium chromate(VI) results in increased expression of WASF2 mRNA | CTD | PMID:22079256 | potassium chromate | multiple interactions | ISO | WASF2 (Homo sapiens) | 6480464 | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of WASF2 mRNA | CTD | PMID:22079256 | resveratrol | decreases expression | ISO | WASF2 (Homo sapiens) | 6480464 | resveratrol results in decreased expression of WASF2 mRNA | CTD | PMID:25667456 | SB 431542 | multiple interactions | ISO | WASF2 (Homo sapiens) | 6480464 | [NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of WASF2 mRNA | CTD | PMID:27188386 | selenium atom | increases expression | ISO | WASF2 (Homo sapiens) | 6480464 | Selenium results in increased expression of WASF2 mRNA | CTD | PMID:19244175 | selenium atom | multiple interactions | ISO | WASF2 (Homo sapiens) | 6480464 | [Selenium co-treated with Vitamin E] results in increased expression of WASF2 mRNA | CTD | PMID:19244175 | sodium arsenite | multiple interactions | ISO | WASF2 (Homo sapiens) | 6480464 | sodium arsenite promotes the reaction [WASF2 protein binds to CAPRIN1 protein] | CTD | PMID:33939924 | sodium arsenite | increases expression | ISO | Wasf2 (Mus musculus) | 6480464 | sodium arsenite results in increased expression of WASF2 mRNA | CTD | PMID:36209798 | sulforaphane | multiple interactions | ISO | Wasf2 (Mus musculus) | 6480464 | [sulforaphane affects the susceptibility to Oxygen] which affects the expression of WASF2 mRNA | CTD | PMID:30529165 | temozolomide | affects response to substance | ISO | WASF2 (Homo sapiens) | 6480464 | WASF2 mRNA affects the susceptibility to temozolomide | CTD | PMID:16365179 | thimerosal | decreases expression | ISO | WASF2 (Homo sapiens) | 6480464 | Thimerosal results in decreased expression of WASF2 mRNA | CTD | PMID:27188386 | thioacetamide | increases expression | EXP | | 6480464 | Thioacetamide results in increased expression of WASF2 mRNA | CTD | PMID:23411599 | titanium dioxide | decreases expression | ISO | Wasf2 (Mus musculus) | 6480464 | titanium dioxide results in decreased expression of WASF2 mRNA | CTD | PMID:23557971 | triticonazole | increases expression | EXP | | 6480464 | triticonazole results in increased expression of WASF2 mRNA | CTD | PMID:36084822 | tungsten | decreases expression | ISO | Wasf2 (Mus musculus) | 6480464 | Tungsten results in decreased expression of WASF2 mRNA | CTD | PMID:30912803 | valproic acid | affects expression | ISO | WASF2 (Homo sapiens) | 6480464 | Valproic Acid affects the expression of WASF2 mRNA | CTD | PMID:25979313 | valproic acid | decreases expression | ISO | WASF2 (Homo sapiens) | 6480464 | Valproic Acid results in decreased expression of WASF2 mRNA | CTD | PMID:29154799 | vitamin E | multiple interactions | ISO | WASF2 (Homo sapiens) | 6480464 | [Selenium co-treated with Vitamin E] results in increased expression of WASF2 mRNA | CTD | PMID:19244175 | vitamin E | increases expression | ISO | WASF2 (Homo sapiens) | 6480464 | Vitamin E results in increased expression of WASF2 mRNA | CTD | PMID:19244175 | vorinostat | decreases expression | ISO | WASF2 (Homo sapiens) | 6480464 | vorinostat results in decreased expression of WASF2 mRNA | CTD | PMID:27188386 | |